ACGN — Aceragen Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $3.20m
- $1.08m
- $4.86m
Brief: Idera Pharmaceuticals Says Cristina Csimma And Michael Dougherty Appointed To Board
Brief: Idera Pharmaceuticals Presents ILLUMINATE-101 Data at the AACR 2019 Annual Meeting
Brief: Idera Pharma Entered Clinical Trial Collaboration & Supply Agreement With Bristol-Myers Squibb, Effective March 11
Brief: Idera Pharmaceuticals Inc Files Prospectus Supplement Related To Issuance And Sale Of Up To $35 Million Shares Of Common Stock
Brief: Idera Pharmaceuticals Reports Fourth Quarter Financial Results
Brief: Idera Pharmaceuticals Inc - Announcing Planned Retirement Of Chief Medical Officer Joanna Horobin - SEC Filing
Brief: Idera Pharmaceuticals Gives Clinical Safety Update For Metastatic Melanoma Drug
Brief: Idera Pharmaceuticals Files For Offering Of Up To $50 Mln Of Common Stock-SEC Filing
Idera Pharmaceuticals: Rises on clinical trial update, smaller Q3 loss
Brief: Idera Pharmaceuticals Reports Q3 Loss Per Share Of $0.43
Idera Pharmaceuticals up as Barclays starts at "overweight"
Brief: Idera Pharmaceuticals Announces Appointment Of Howard Pien To Its Board Of Directors
Brief: Idera Pharmaceuticals Q2 Loss Per Share $0.59
Idera Pharmaceuticals Inc: Hits lowest in over 5-yrs
Brief: Idera Pharmaceuticals Announces One-For-Eight Reverse Stock Split
Brief: Idera Pharmaceuticals Says Ended Q1 With Cash, Cash Equivalents Of $107.5 Mln
U.S. STOCKS ON THE MOVE-American Airlines, Fox, Fastenal, Keurig Dr Pepper, auto makers
U.S. STOCKS ON THE MOVE-Fox, Disney, auto makers, Fastenal, chipmakers
BioCryst Pharma: Gains after calling off merger plans with Idera Pharma